Arrow Projects for Medical Research Education, The Chaim Sheba Medical Center, Tel Hashomer 5266202, Israel.
Department of Imaging, The Chaim Sheba Medical Center, Tel Hashomer 5266202, Israel.
Nutrients. 2024 May 3;16(9):1387. doi: 10.3390/nu16091387.
Obesity is associated with metabolic syndrome and fat accumulation in various organs such as the liver and the kidneys. Our goal was to assess, using magnetic resonance imaging (MRI) Dual-Echo phase sequencing, the association between liver and kidney fat deposition and their relation to obesity.
We analyzed MRI scans of individuals who were referred to the Chaim Sheba Medical Center between December 2017 and May 2020 to perform a study for any indication. For each individual, we retrieved from the computerized charts data on sex, and age, weight, height, body mass index (BMI), systolic and diastolic blood pressure (BP), and comorbidities (diabetes mellitus, hypertension, dyslipidemia).
We screened MRI studies of 399 subjects with a median age of 51 years, 52.4% of whom were women, and a median BMI 24.6 kg/m. We diagnosed 18% of the participants with fatty liver and 18.6% with fat accumulation in the kidneys (fatty kidneys). Out of the 67 patients with fatty livers, 23 (34.3%) also had fatty kidneys, whereas among the 315 patients without fatty livers, only 48 patients (15.2%) had fatty kidneys ( < 0.01). In comparison to the patients who did not have a fatty liver or fatty kidneys ( = 267), those who had both ( = 23) were more obese, had higher systolic BP, and were more likely to have diabetes mellitus. In comparison to the patients without a fatty liver, those with fatty livers had an adjusted odds ratio of 2.91 (97.5% CI; 1.61-5.25) to have fatty kidneys. In total, 19.6% of the individuals were obese (BMI ≥ 30), and 26.1% had overweight (25 < BMI < 30). The obese and overweight individuals were older and more likely to have diabetes mellitus and hypertension and had higher rates of fatty livers and fatty kidneys. Fat deposition in both the liver and the kidneys was observed in 15.9% of the obese patients, in 8.3% of the overweight patients, and in none of those with normal weight. Obesity was the only risk factor for fatty kidneys and fatty livers, with an adjusted OR of 6.3 (97.5% CI 2.1-18.6).
Obesity is a major risk factor for developing a fatty liver and fatty kidneys. Individuals with a fatty liver are more likely to have fatty kidneys. MRI is an accurate modality for diagnosing fatty kidneys. Reviewing MRI scans of any indication should include assessment of fat fractions in the kidneys in addition to that of the liver.
肥胖与代谢综合征以及肝脏和肾脏等各种器官的脂肪堆积有关。我们的目标是使用磁共振成像(MRI)双回波相位序列评估肝和肾脂肪沉积之间的关联及其与肥胖的关系。
我们分析了 2017 年 12 月至 2020 年 5 月期间因任何原因到 Chaim Sheba 医疗中心进行研究的个体的 MRI 扫描。对于每个个体,我们从计算机图表中检索有关性别,年龄,体重,身高,体重指数(BMI),收缩压和舒张压(BP)以及合并症(糖尿病,高血压,血脂异常)的数据。
我们筛选了 399 名具有中位年龄 51 岁,52.4%为女性和中位 BMI 24.6 kg/m 的个体的 MRI 研究。我们诊断出 18%的参与者患有脂肪肝,18.6%的参与者有肾脏脂肪堆积(脂肪肝)。在 67 名脂肪肝患者中,有 23 名(34.3%)患者同时患有脂肪肝,而在 315 名无脂肪肝患者中,只有 48 名(15.2%)患者有脂肪肝(<0.01)。与无脂肪肝或脂肪肝的患者(= 267)相比,同时患有脂肪肝和脂肪肝的患者(= 23)更肥胖,收缩压更高,并且更可能患有糖尿病。与无脂肪肝的患者相比,患有脂肪肝的患者患脂肪肝的调整优势比为 2.91(97.5%CI;1.61-5.25)。总的来说,有 19.6%的个体肥胖(BMI≥30),有 26.1%的个体超重(25<BMI<30)。肥胖和超重的个体年龄较大,更可能患有糖尿病和高血压,并且脂肪肝和脂肪肝的发生率更高。在 15.9%的肥胖患者,8.3%的超重患者和没有正常体重的患者中观察到肝脏和肾脏的脂肪沉积。肥胖是脂肪肝和脂肪肝的唯一危险因素,调整后的 OR 为 6.3(97.5%CI 2.1-18.6)。
肥胖是发生脂肪肝和脂肪肝的主要危险因素。患有脂肪肝的个体更有可能患有脂肪肝。 MRI 是诊断脂肪肝的准确方法。在审查任何适应症的 MRI 扫描时,除了评估肝脏的脂肪分数外,还应评估肾脏的脂肪分数。